Skip to main content
. 2019 Jan 15;4(1):1272–1280. doi: 10.1021/acsomega.8b02207

Figure 3.

Figure 3

Apo F identified as the strongest biomarker for HF. (A) When stratified by age, sex, and time interval between MI and plasma collection, Apo F was associated with increased risk, and ICAM1 and LRRN2 were associated with decreased risk from the development of HF. (B) Apo F and (C) CD59 alone were strong predictors for HF compared to (D) all eight proteins combined (Apo F, transthyretin, Apo C4, prostaglandin-H2 D-isomerase, complement C9, CD59, ICAM1, and LRRN2).